Načítá se...
Cardioprotection: The Role of β‐Blocker Therapy
Randomized controlled clinical trials document that β blockers reduce cardiovascular morbidity and mortality, particularly sudden death, in patients with hypertension, heart failure, and post‐myocardial infarction. The benefits of β blockers extend across the boundaries of age, gender, and ethnicity...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Le Jacq Ltd.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109701/ https://ncbi.nlm.nih.gov/pubmed/16015051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2005.04486.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|